Actarit

Actarit
Clinical data
ATC code	none;
Identifiers
	IUPAC name 4-(Acetylamino)-benzeneacetic acid;
CAS Number	18699-02-0 ;
ChemSpider	1941 ;
UNII	HW5B6351RZ;
KEGG	D01395 ;
ChEMBL	ChEMBL1226203 ;
CompTox Dashboard (EPA)	DTXSID0020020 ;
ECHA InfoCard	100.038.631
Chemical and physical data
Formula	C10H11NO3
Molar mass	193.20 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)Cc1ccc(cc1)NC(=O)C;
	InChI InChI=1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14) ; Key:MROJXXOCABQVEF-UHFFFAOYSA-N ;
	(what is this?) (verify)

Actarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.^[1]

References

^ Takeba, Y; Suzuki, N; Wakisaka, S; Nagafuchi, H; Mihara, S; Kaneko, A; Asai, T; Sakane, T (Jan 1999). "Effects of actarit on synovial cell functions in patients with rheumatoid arthritis". The Journal of rheumatology. 26 (1): 25–33. ISSN 0315-162X. PMID 9918236.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.